SEC 13F Intelligence

Capital Research Global Investors / GILD

Capital Research Global Investors’s Gilead Sciences Inc Position

Does Capital Research Global Investors own Gilead Sciences Inc (GILD)? Yes — 27.13M shares worth $3.8B (+0.59% of its 13F portfolio) as of Q1 2026, up from 25.31M shares the prior filed quarter.

Position Value
$3.8B
Q1 2026
Shares
27.13M
% of Portfolio
+0.59%
Quarters Held
30
currently held

Position History GILD

Reported value by quarter
Q4 ’18: $4.5BQ4 ’18Q1 ’19: $5.1BQ2 ’19: $5.5BQ3 ’19: $4.9BQ4 ’19: $5.5BQ4 ’19Q1 ’20: $7.2BQ2 ’20: $9.6BQ3 ’20: $7.4BQ4 ’20: $7.1BQ4 ’20Q1 ’21: $7.9BQ2 ’21: $8.0BQ3 ’21: $8.0BQ4 ’21: $7.8BQ4 ’21Q1 ’22: $3.3BQ2 ’22: $3.5BQ3 ’22: $3.3BQ4 ’22: $4.7BQ4 ’22Q1 ’23: $4.8BQ2 ’23: $4.5BQ3 ’23: $4.3BQ4 ’23: $4.8BQ4 ’23Q1 ’24: $4.5BQ2 ’24: $4.1BQ3 ’24: $5.2BQ4 ’24: $5.4BQ4 ’24Q1 ’25: $6.1BQ2 ’25: $3.4BQ3 ’25: $3.3BQ4 ’25: $3.1BQ4 ’25Q1 ’26: $3.8Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202627.13M$3.8B+0.59%
Q4 202525.31M$3.1B+0.57%
Q3 202530.01M$3.3B+0.63%
Q2 202531.10M$3.4B+0.69%
Q1 202554.61M$6.1B+1.33%
Q4 202457.95M$5.4B+1.10%
Q3 202461.80M$5.2B+1.08%
Q2 202460.43M$4.1B+0.91%
Q1 202461.25M$4.5B+1.02%
Q4 202359.66M$4.8B+1.19%
Q3 202357.91M$4.3B+1.20%
Q2 202357.90M$4.5B+1.20%
Q1 202358.28M$4.8B+1.38%
Q4 202254.60M$4.7B+1.42%
Q3 202253.88M$3.3B+1.09%
Q2 202255.98M$3.5B+1.08%
Q1 202255.95M$3.3B+0.82%
Q4 2021107.16M$7.8B+1.72%
Q3 2021114.55M$8.0B+1.87%
Q2 2021116.67M$8.0B+1.87%
Q1 2021122.61M$7.9B+1.94%
Q4 2020121.67M$7.1B+1.84%
Q3 2020117.11M$7.4B+2.22%
Q2 2020125.36M$9.6B+3.05%
Q1 202095.98M$7.2B+2.82%
Q4 201985.13M$5.5B+1.66%
Q3 201976.79M$4.9B+1.60%
Q2 201981.75M$5.5B+1.75%
Q1 201978.19M$5.1B+1.61%
Q4 201872.55M$4.5B+1.58%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capital Research Global Investors’s full portfolio or all institutional holders of GILD.